TMED2 and metabolic dysfunction-associated steatotic liver disease: Work from our laboratory showed that Tmed2 may play a role in the progression of non-alcoholic fatty liver disease (NAFLD) (Hou et al., 2017), which is the major cause of chronic liver disease worldwide (Abd El-Kader & El-Den Ashmawy, 2015).